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Abstract
The use of dimethyl sulfoxide (Me2SO) as a cryoprotectant agent (CPA) is
controversial. Indeed, this cryoprotectant agent (CPA) is cytotoxic and potentially
mutagenic. Therefore, other cryoprotectants must be used to reduce the proportion
of Me2SO in slow-freezing solutions. In this chapter, we propose to present the first
evaluation of new non-penetrating cryoprotectants: the chitooligosaccharides
(COS). These molecules are chitosan oligomers, which are biocompatible, antioxi-
dant, and bacteriostatic. We first review the use of saccharides through cryopreser-
vation processes. We question the possibility to reduce penetrating CPA during
slow-freezing procedures. We propose to use COS as extracellular CPA to reduce
the use of Me2SO. We question the biocompatibility of COS on mouse embryos
through the analysis of the cells’ development. Next, we evaluate these molecules in
slow-freezing solutions with a reduced quantity of Me2SO. Our experimental
approach is a physical method often used to characterize slow-freezing solutions.
Differential scanning calorimetry (DSC) allows to evaluate the crystallization and
melting processes, the amount of crystallized water, and the equilibrium tempera-
ture and consequently to evaluate the impact of different cryoprotectants. This
study gives a better understanding on how slow-freezing protocols could be
improved with extracellular CPA.
Keywords: slow-freezing improvement, chitooligosaccharides, dimethyl sulfoxide,
physical approach, differential scanning calorimetry
1. Introduction
Despite the progress achieved these last decades, the improvement of cryopres-
ervation procedures is still desired by the scientific community [1, 2]. A possible
improvement is the decrease of the penetrating cryoprotective agents (CPA). The
small and osmotically active penetrating molecules used as penetrating CPA in
cryopreservation present risks of cytotoxicity for cells [3–6]. These molecules pen-
etrate easily into tissues and, after impregnation, are difficult to fully extract from
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biological systems. Among the different penetrating CPA, Me2SO is a penetrating
CPA especially efficient to promote successful cryopreservation. However, the
Me2SO molecule presents risks of toxicity to biological materials [7–14]. It is also
suspected to be an intercalator of DNA [15]. In this chapter, we propose to study the
possibility to reduce the use of the Me2SO molecule while maintaining the survival
rate of cells in slow-freezing cryopreservation.
A challenge of modern cell cryopreservation is to propose procedures in which
CPA concentration is as little as possible:
• In vitrification procedures, the techniques seek to obtain the glassy state with
very small amounts of penetrating CPA (less than 25% (w/w)) by replacing
them with non-penetrating CPA [3, 16–18]. Accordingly, the cooling must be
applied as quickly as possible so that the cells do not suffer the damage
associated with excessive dehydration and/or volume loss at room
temperature. They also require the use of particularly small sample volumes
(<1 μL) to reach high cooling rate that will prevent ice crystallization. These
procedures are particularly delicate and require a certain dexterity of the
experimenter [19, 20].
• In slow-freezing procedures, reducing the initial amount of penetrating CPA
significantly increases the stresses and risks experienced by cells during
cryopreservation. It is therefore difficult to propose an excessive reduction in
the initial concentration of penetrating CPA. Indeed, it has been theoretically
demonstrated, through mathematical modeling, that it is impossible to
cryopreserve cells with initial Me2SO concentrations below 1 mol.L
1 [21].
We assume, however, that a good combination of penetrating and non-
penetrating CPA and an adaptation of the slow-freezing protocols could provide
satisfactory survival rates, despite a reduction in the initial proportion of Me2SO
used. This chapter investigates an alternative to the current slow-freezing proce-
dures using Me2SO and proposes procedures where the initial and necessary amount
of Me2SO is lowered.
Decreasing the Me2SO proportion in solution will modify the couple “protocol/
solution” within the cryopreservation procedure since it is necessary to counterbal-
ance the loss of the cryoprotective effect of the removed Me2SO molecules. To that
end, this chapter studies the possibility to use chitooligosaccharide (COS) com-
pounds in solution. The role of extracellular CPA is discussed, and the effect of the
COS in solution is thermodynamically evaluated.
Even if common characteristics of various CPA can be defined, the substances
currently used as CPA have different chemical structures and sizes, so it is still
difficult to predict the cryoprotective properties of substances from their basic
chemical structures. The modes of action of cryoprotectants have not yet been fully
elucidated. Thus, the development of effective cryopreservation solutions remains
primarily based on empirical considerations. Consequently, studying the potential
cryoprotective characteristics of new compounds serves a dual purpose: (1) propose
new cryoprotectants and (2) understand the mechanisms of cryoprotection. It
makes possible to better classify the molecules according to their modes of action
regarding cellular cryoprotection.
This chapter aims to assess the use of COS to fulfill part of the cryoprotective
role of the Me2SO. It presents first, from the cellular cryopreservation point of view,
the interesting properties of saccharides (Part 2). It discusses next the optimization
of the procedures required to replace a part of the penetrating CPA by using non-
penetrating saccharides (Part 3). The use of COS to realize this optimization is
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explained (Part 4). Then, COS synthesis is presented from a physicochemical point
of view (Part 5). The biocompatibility of COS on mouse embryos is questioned
(Part 6), and a first understanding of the action of COS as cryoprotectants is
quantified by DSC analysis (Part 7), before a conclusion on the possibility of using
these compounds as non-penetrating CPA.
2. State of the art: the use of saccharides in cryopreservation
The cryoprotective role of saccharide compounds (mono-, di-, tri-, oligo-, or
polysaccharides) is known for a long time. Some of them are secreted by certain
cold-blooded organisms that withstand harsh winters [22, 23]. Several saccharides
are water soluble, have a high osmotic effect, and have many influences on the
solutions’ properties: they can bind part of the water and make it non-crystallizable
[24–29]; their action on viscosity [30, 31] has been highlighted, as well as their
ability to disrupt the organization of water molecules in the liquid phase [32–35]. In
a mixture of “H2O/saccharide compound,” the proportion of water has an influence
on the properties of the saccharide compound and therefore on the properties of the
mixture [29, 36].
These compounds are known to be unable to penetrate passively through most
cell membranes. From the cryoprotective point of view, they act outside the cells,
giving them limited action on cell protection. This is the reason why the standard in
cryopreservation procedures remains the massive use of penetrating CPA that pos-
sess a high osmotic effect in both extra- and intracellular solutions. However, the
beneficial use of saccharides to substitute penetrating CPA compounds has been
proven in recent years. Indeed, saccharides have been used for cell cryopreservation
in slow-freezing [37–51] or vitrification procedures [16–18, 39, 52–55]. A non-
exhaustive overview from the literature of the use of the saccharides is displayed in
Table 1.
Using empirical methods, it has been shown that these compounds allow the
improvement of the post-cryopreservation survival rates of certain cell types [3, 37,
38, 44–48, 82]. Some authors have discussed the benefits of using them:
• Meryman was the first to propose that the presence of large polymers in
solutions prevents the risks of osmotic shocks (when the penetrating CPA are
released from the intracellular medium) as well as the denaturation of cell
membranes [83].
• In cryopreservation of spermatozoa, small saccharides are often used as
substituents for penetrating CPA [42, 49, 50, 61]. The advanced argument of
their use is that they increase the viscosity, increase the glass-forming
tendency, and protect the cellular lipid membranes [42, 61, 82].
Monosaccharides Disaccharides Trisaccharide
Glucose [56–63] Sucrose [61, 64–67] Raffinose [14]
Fructose [14] Maltose [35] Polysaccharides
Sorbitol [14] Trehalose [16, 35, 39–43, 49–51, 61, 68–79] Dextran [1, 2, 17, 18, 54, 67, 80, 81]
Mannitol [14]
Galactose [64] Ficoll [1, 17, 18, 54, 64, 66, 81]
Table 1.
Non-exhaustive directory from literature of saccharides used in cryopreservation procedures.
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• In cryopreservation by vitrification, Kuleshova et al. [17] proposed to replace a
large portion of penetrating CPA by large extracellular polysaccharides (Ficoll
and dextran).
• In slow-freezing cryopreservation, saccharides have also been used [84]. For
the cryopreservation of human or mouse embryos, Dumoulin et al. [81]
highlighted the ability of large molecules (e.g., dextran) to reduce damage to
zona pellucida when added in small amounts (i.e., less than 10% (w/v)). For
the cryopreservation of cat embryos, Gómez et al. [67] were able to obtain
interesting survival rates (>80%) by combining propylene glycol (1.4 M),
sucrose (0.125 M), and dextran 10% (w/w). Slow-freezing procedures for
some weak cellular systems have been proposed, without recourse to CPA
penetrants [43]. This strategy is based on the induction, prior to ice formation,
of cellular dehydration using osmotically active extracellular compounds (e.g.,
trehalose).
• For the slow-freezing cryopreservation of human red blood cells, Bailey et al.
[85] reported the possibility to reduce the use of Me2SO from 10% (w/w) to
2.5% (w/w) through the use of high concentration of copolymers
(polyampholytes). These authors concluded that because no ice
recrystallization inhibition (IRI) activity could be seen, the interaction of those
copolymers with cells’ membranes should be the reason that increases the cell
recovery.
From these readings, mechanisms can be advanced to explain how the addition
of saccharides in solution improves cell survival:
• Saccharides have a cryoscopic influence in the extracellular medium [86]. It
reduces the damage associated with the formation and growth of the crystalline
phase.
• Saccharides promote cell dehydration on cooling [17]. This aspect is
ambivalent because, on the one hand, it allows to promote intracellular
vitrification, but on the other hand, it increases the risks associated with
cellular dehydration.
• Saccharides reduce the cellular rehydration during warming [19, 83]. By
having an osmotic effect from the extracellular medium, they limit the osmotic
gap (appeared during cooling, due to the difference between the intra- and the
extracellular vitrification temperature [87]) between intra- and extracellular
media. During warming and during the ice melting, saccharides guarantee a
smoother return of water into the cells [19, 83].
• Saccharides participate in the evolution of extracellular viscosity. This reduces
the kinetics of crystal growth and favors the deviation of the system from its
equilibrium position. This effect has the consequence of improving the
extracellular vitreous state achievement [17].
• Saccharides allow to “encapsulate” cells. Thus, the presence of large molecules
in solution protects the zona pellucida of embryos during slow-freezing
procedures [81]. Likewise, the presence of these large molecules can move the
cells away from the ice in the overconcentrated amorphous phase [82]. It has
been also reported that the presence of mono- or disaccharides in solution
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improves sperm motility after cryopreservation [88]. Finally, it has been
proposed to create hydrogel-based microspheres to encapsulate cellular
systems in small volumes [89].
• Saccharides promote the lipid transition of phospholipids from cell
membranes. By interacting with cell membranes, saccharides have an effect on
the fluidity of lipidic membranes [82, 83]. Interactions between membrane
phospholipids and saccharides in solution have also been advanced as a method
of promoting the success of cryopreservation procedures [90, 91].
Saccharidic CPA are used in different ways depending on their physicochemical
characteristics. In general, the polysaccharides are added in solution to increase the
viscosity while having a weak osmotic activity. On the contrary, the small saccha-
ride molecules (such as glucose) are added in solution to have high osmotic activity
within the solution (this favors and induces the cellular dehydration), without
changing the viscosity too much.
3. Strategy for improving slow-freezing cryopreservation procedures
3.1 Foundations of the strategy
Models showed that the improvement of cryopreservation procedures is impos-
sible if it implies an excessive reduction in the use of penetrating CPA (<1 mol.L1)
[21]. But these models studied this reduction without trying to use other CPA
compounds with completely different properties than those currently used. Me2SO
is certainly one of the best compounds to fulfill the roles that are required to a CPA
(apart from its cytotoxicity), but it is conceivable that a combination of different
CPA may also be compatible with cell survival.
To reduce the use of Me2SO in slow-freezing cryopreservation procedures, sev-
eral assumptions were considered, based on results published in the literature:
a. The slow-freezing procedures have been optimized according to some
parameters, but new optimizations are possible.
Other combinations of the parameters may be better than the currently used.
The search for new CPA is still ongoing, and the cryopreservation procedures are
better understood. The discovery of intracellular vitreous transitions [87], the
control of the IRI process [92], the development of new cooling or warming
techniques [93], etc. may suggest that optimization of the procedure is still possible.
b. The optimization of the proportion of penetrating CPA in the
cryopreservation solution is considered in order to find a formulation offering
good vitrification conditions for the remaining solution.
It has been shown that the proportion of penetrating CPA necessary to lead to a
cellular vitrification can be reduced if there is a high cellular dehydration [16].
Indeed, the intracellular cytoplasmic medium has a great glass-forming tendency
because of the presence of many macromolecules [87, 94–96]. The presence in
intracellular solution of a large proportion of proteins and other organic compounds
(macromolecules), accompanied by dehydration of the medium, is sufficient to
promote vitrification [87, 94]. In addition, experiments have shown the existence of
colloidal glass transitions in cells during their dehydration [96, 97]. These
transitions can promote intracellular vitrification and potentially protect cells (since
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cell cytoplasm is often heavily loaded with large molecules, it can easily vitrify
[17, 59, 96]). In a vitrification procedure, using successive baths of osmotic
equilibration, the cells are placed in solutions containing penetrating CPA. It was
proposed by Kuleshova et al. [17] to replace, in those procedures, a large proportion
of penetrating CPA with non-penetrating polymers (PVP, dextran, Ficoll, etc.). In
the last osmotic equilibration bath, non-penetrating CPA (sugars or polymers) are
added to promote cell dehydration just before the plunge into liquid nitrogen
(LN2). The osmotic effect of these non-penetrating CPA promotes the vitrification
of the intracellular medium and ensures the success of the procedure with a lower
amount of penetrating CPA [16]. By adaptation to slow-freezing procedures, we
assume that it is possible to force the intracellular colloidal glass transition to the
correct temperature by suitably combining temperature lowering and cellular
dehydration. However, cellular dehydration is not possible over long periods when
the temperature remains high. During a vitrification procedure, the dehydration
time is short (primarily applied during the last osmotic bath, a few seconds before
the plunge into LN2). During slow-freezing, if the dehydration intervenes too
extremely, it could lead to cellular collapse [83, 98, 99]. To solve this problem, we
rely on the work of Mazur et al. [100] who proposed an alternative to conventional
cellular cryopreservation protocols by rapidly bringing the cells to a temperature
low enough to make the effects of cell dehydration less deleterious. This
temperature must, however, remain above the nucleation temperature of the
intracellular medium. A temperature stabilization is then carried out at this
intermediate temperature to allow the equilibration of the media. Then, the cooling
continues at a slow cooling rate until the plunge into LN2. This type of protocol is
called “rapid cooling interrupted” [100]. It should be noted that this protocol also
possesses a seeding step in order to control the extracellular ice growth. We assume
that, when using this type of protocol, it would be possible to allow faster cell
dehydration already biologically tolerated in the case of vitrification procedures.
c. The use of non-penetrating CPA can allow reducing the necessary proportion
of penetrating CPA by optimizing the procedure of cooling and warming.
For a slow-freezing procedure, in which ice formation is allowed and desired,
the osmotic effect of a non-penetrating CPA becomes increasingly important as the
proportion of water in the remaining extracellular medium decreases. Conversely,
in the intracellular medium, it is mainly the penetrating CPA that participates in the
osmotic balance. There is therefore a gap between these two media in the osmolality
evolution, which accentuates cellular dehydration and increases cell contraction at a
given cooling rate. The use of an osmotically active non-penetrating CPA in solution
may induce a significant change in the osmolality difference between the intra- and
the extracellular media.
3.2 The elements of the proposed optimization
The toxicity of the cryopreservation solutions is related to the CPA concentration
reached in the remaining solution to enable the vitrification of the intracellular
medium. Moreover, to protect the cells, the vitrification must also be carried out in
the noncrystalline extracellular medium in contact with the cells. Intracellular vitrifi-
cation is dependent on the presence of penetrating CPA and on the cellular dehydra-
tion. In consequence, the intracellular vitrification is dependent on the diffusion of
materials across the cellular membrane. That is why cryopreservation procedures are
time dependent. Indeed, an ideal cooling rate exists at which, for a specific cell (i.e., a
specific permeability and cell size), the cellular dehydration is ideally compensated by
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the CPA penetration. This rate deals with the two major risks of the slow-freezing
procedures, the “solute effect,”which occurs at low cooling rate, and the intracellular
nucleation, which occurs at high cooling rate [101].
The addition of penetrating CPA in a solution, in a reasonable proportion (> 1 mol.
L1 for slow-freezing and > 3 mol.L1 for vitrification), is considered essential for the
survival of mammalian embryo type cells [21]. Very few studies have been published
on attempts to reduce the amount of Me2SO in solution during slow-freezing cryo-
preservation [43, 84]. This strategy was evaluated by relying on modeling arguments,
showing that it seems complicated to reduce this initial proportion of penetrating CPA
[21]. We make a proposal for slow-freezing procedure optimization using a reduced
initial proportion of penetrating CPA, supplemented with non-penetrating CPA.
The decrease of the initial proportion of penetrating CPA implies an increase in
the amount of crystallizable water, a stronger evolution of the crystal/liquid ratio in
the solution with temperature, a higher amount of penetrating CPA needed to
diffuse through the membrane, more risks of contact between cells and ice crystals,
etc. Thus, penetrating CPA play a cryoprotective role that cannot be fully
reproduced in the extracellular environment by non-penetrating CPA. Moreover,
the stresses and risks associated with the ice formation must be limited or prevented
until the plunge to LN2. It is therefore necessary to continue to use penetrating CPA,
but their amount in the initial solution should be limited to reduce cytotoxicity. In
addition to the presence of penetrating CPA, the vitrification of the extracellular
remaining solution depends on the presence of non-penetrating CPA that limit the
evolution of penetrating CPA concentrations and reduce the risks associated with
the ice formation in solution. The reduction of penetrating CPA implies to control
the damages related to the ice formation in solution by replacing a large part of the
initial extracellular water by non-crystallizable substances, which offer favorable
conditions for cryopreservation. However, the biocompatibility of these com-
pounds on the cellular systems must be guaranteed.
Because the proportion of CPA in the intracellular medium has a lighter impact
than the cellular dehydration on the intracellular vitrification [16, 87, 94–96], we
assume that the proportion of penetrating CPA may be limited. In that case, it is
then necessary to reduce the deleterious effects related to the cellular dehydration
by using non-penetrating CPA that are not highly osmotically active and whose
molar concentrations slightly change during cooling (i.e., compounds with a large
molar mass). It is also necessary to employ the “fast interrupt protocol” by suitably
combining dehydration and lowering temperature so that the colloidal intracellular
transition occurs before cell dehydration becomes too important.
Finally, it is necessary to verify that the extracellular remaining solution can
vitrify easily so that the cryopreservation procedure can be interrupted at a higher
plunge temperature into LN2. Thus, the use of cryostabilizer CPA that facilitate the
achievement of the vitreous state, without binding a significant amount of water,
may promote the stabilization of the system “ice/remaining solution” (by reducing
the risk of recrystallization of the intercrystalline remaining solution).
We chose to study the possibility to cryopreserve mouse embryos with 5% (v/v)
of Me2SO in the initial solution, supplemented with non-penetrating CPA (COS).
4. The proposition to use COS
The idea of using COS compounds in cell cryopreservation is supported by:
• An absence of toxicity, an ability to degrade without toxic residues, and a
biocompatibility [102].
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• Bacteriological, fungistatic, and antitumor properties [102–106].
• An ability to be soluble in aqueous solutions at physiological pH [107].
• A tendency to form aggregates in aqueous media [108].
• A chemical structure of oligosaccharide type close to molecules currently used
in cryobiology.
• Potential interactions with water and consequently a potential effect on the
properties of aqueous solutions (like that proposed by mono-, di-, and
oligosaccharides).
In addition, because of the length of their chains, the COS propose intermediate
properties between the polymers and the mono- or disaccharides. These properties
are adjustable since the length of the chains can be selected during their synthesis
using degree of polymerization (DP) parameter as well as the nature of the mono-
mers present on the chain using the degree of acetylation (DA) parameter. These
modular characteristics let us hope for the attainment of physicochemical properties
that are adjustable for use as a CPA. Furthermore, they are particularly biocompat-
ible and nontoxic. As a result, addition of COS to some penetrating CPA appears to
be a relevant choice to reduce the needed amount of CPA during slow-freezing.
Assuming that a use of COS would reduce the use of Me2SO, this work proposes
to look for a composition of COS-based solution that can reproduce, in the extra-
cellular medium, some effects of Me2SO (favor the vitrification of the intracellular
medium, promote the vitrification of the intercrystalline remaining solution, reduce
the cell dehydration, etc.).
Our current procedure used for mouse embryo cryopreservation has been opti-
mized for the “IMV” holding medium (embryo-holding medium, IMV® Technolo-
gies, L’Aigle, France) supplemented with approximately 10% (v/v) Me2SO [109].
We set the goal of reducing by 50% the proportion of Me2SO, to successfully
cryopreserve mouse embryos using an IMV + 5% (v/v) Me2SO solution containing a
certain amount of COS.
5. Synthesis and chemical characterization of COS
The basic compound used to synthesize COS is chitosan supplied by the Indian
company Mahtani Chitosan®. This chitosan (batch 244/020208) is produced from
chitin extracted from shrimp shells. The chitosan provided was almost completely
deacetylated (DA < 0.5%) by deacetylation reaction. This chitosan has a number-
average molecular weight of 115 kg.mol1 and dispersity of 2.3. For the preparation
of COS, the macromolecular chitosan chains are depolymerized according to a
nitrous acid deamination reaction using sodium nitrite (NaNO2) in acidic condi-
tions [110]. It is only possible to obtain a statistical average chain length distribution
around a mean DP value. To control the DA parameter, it is possible to perform an
N-acetylation reaction of the D-glucosamine units with acetic anhydride as acetyla-
tion agent. In this chapter, DP and DA parameters have been used to name the COS
as follows: COSDP_DA, with DP = “the average number of monomers per COS
chain” and DA = “the average degree of acetylation of the chains of this COS.”
To estimate the residual hydration rate in purified COS, we used data from the
literature. A previous study of the same types of chitosan chains, but in a polymeric
form, evaluated these hydration levels [111]. This study performed by
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thermogravimetric analysis has shown that there are residual hydration levels after
synthesis, purification, and lyophilization, which are variable according to the DA
parameter of the chitosan polymers chains. From this data, we extrapolated the
hydration levels of the COS compounds according to the DA parameter. For a
DA ≈ 0%, we considered a residual hydration value of the COS compound equal to
6.5% (w/w). This is consistent with other results published in the literature where a
value of 6% (w/w) was obtained [112].
6. Questioning the biocompatibility of COS
Before considering the use of COS in cryopreservation solutions, an evaluation
of its biocompatibility is necessary. It ensures that their presence will not be delete-
rious to the future survival and development of the cryopreserved biological sys-
tem. By their nature and chemical composition, the biocompatibility of COS has
already been emphasized [113]. However, the molecular interactions between all
the compounds in extracellular solution and the cell membranes are complex. There
are, for example, interactions between COS molecules and cell membranes that are
invoked to explain their fungistatic and bacteriostatic properties [113]. It is there-
fore not excluded that interactions may exist with eukaryotic cells. In addition, the
cell system chosen for this study, the mouse embryo, is a fragile system whose
development can be disrupted by the presence of harmful materials. Consequently,
deleterious influence on this cellular system, linked to COS, must be excluded.
6.1 Materials and methods
The biocompatibility of COS was evaluated with mouse embryos. A procedure
identical to that presented in a previous team article [109] was applied for the
production of embryos used in this study. To study the biological action of COS on
mouse embryos, a large quantity of COS10_0 (150 mg.mL1) was dissolved in the
cryopreservation solution (IMV + 5% (v/v) Me2SO) and in the “IMV” holding
medium. One hundred twenty-six embryos (morula stage) were collected and were
then mixed and divided into five groups (cf. Table 2): (1) “IMV,” a control group
placed in a solution without CPA; (2) “IMV + 10% (v/v) Me2SO,” a control group
placed in the solution conventionally used for cryopreservation of mouse embryos;
(3) “IMV + 5% (v/v) Me2SO,” a control group placed in the solution in which COS
Groups pH Number of
embryos in culture
Young
blastocysts
Expanded
blastocyst
Hatching
1 IMV 7.29 25 23 92% 23 92% 23 92%
2 IMV + 10% (v/v) Me2SO 7.29 25 20 80% 18 72% 14 56%
3 IMV + 5% (v/v) Me2SO 7.30 25 23 92% 20 80% 20 80%
4 IMV + 5% (v/v) Me2SO +
(150 mg.mL1) COS10_0
7.32 25 25 100% 22 88% 20 80%
5 IMV + (150 mg.mL1) COS10_0 7.34 26 24 92% 23 88% 23 88%
The stage reached by the embryos was evaluated under a binocular microscope every 24 hours for 4 days. For each
embryonic stage, the number of embryos observed at this stage is indicated in the left column and, on the right, the
corresponding percentage in relation to the initial number of cultured embryos.
Table 2.
Compilation of embryonic developments observed by groups.
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are diluted; (4) “IMV + 5% (v/v) Me2SO + (150 mg.mL
1) COS10_0,” a test group
placed in a tested cryopreservation solution with COS; and (5) “IMV + (150 mg.
mL1) COS10_0,” a second test group, without Me2SO, studied to highlight the
effect of COS and avoid the potentially cross-cutting effects between COS and
Me2SO.
The embryos were placed in these solutions at room temperature for 10 minutes.
They were rinsed with M16 culture medium (IMV® Technologies, L’Aigle, France)
and then placed in a culture chamber. The culture medium was equilibrated in the
incubator (+37°C; 5% (v/v) CO2; humid atmosphere), and then the embryos were
introduced therein. The culture was maintained and supervised for 4 days. The
development of embryos was then compared (every 24 hours) with other control
groups to assess the state of the embryonic stage reached by each embryo. These
comparisons can highlight certain harmful effects related to the presence of the
different products on cellular development.
6.2 Results and discussions
After 24 hours, 20% of the embryos in the 10% (v/v) Me2SO group failed to reach
the “young blastocyst” stage. For groups with 5% (v/v) Me2SO, the development
stage remains similar to the solution without Me2SO. The presence of COS does not
appear to have a deleterious effect on the development of embryos at this stage, and
the reduction in the proportion of Me2SO in solution seems to be beneficial.
After 48 hours, it is possible to compare the number of embryos which reached
the “expanded blastocyst” stage to the number of embryos which previously
reached the “young blastocyst” stage. The numbers are the same for group 1 (con-
trol without CPA and COS), while an embryo did not develop in group 5 (with COS
but without CPA), and more than one embryo did not develop in the other groups
(2, 3, and 4). By comparing the results for groups 3 and 4, the effect of COS
presence on embryo development may be considered minimal. Conversely, the
decrease in the number of living embryos in groups 2, 3, and 4 seems to be directly
associated with the presence of Me2SO in the solution where embryos are bathed at
room temperature.
After 72 hours, the number of embryos that reached the hatching stage is the
least important for group 2 (with 10% (v/v) Me2SO). There is no difference
according to the presence or absence of COS in the IMV, and the final percentage in
each case is very close. It is the same in solutions with 5% (v/v) Me2SO, where the
number of embryos which reached this stage of development is equivalent, with or
without COS.
According to this study repeated only once, a negative effect of Me2SO on the
development of mouse embryos is highlighted. However, a negative effect of COS
on this cellular development is discarded. These results should be repeated but seem
to demonstrate the biocompatibility of COS for the mouse embryos. We conclude
that COS can be used in the cryopreservation solutions in contact with cells.
7. Thermodynamic characterization of cryopreservation solutions
containing COS
The strategy outlined in Part 3 aims to reduce by 50% the initial volume pro-
portion of Me2SO in slow-freezing solutions with the help of COS. It is thus neces-
sary to know more precisely their mode of action in aqueous solutions. Several
studies have already proposed the thermodynamic characterization of chitosan or
chitosan derivatives [26, 112, 114–116]. However, these studies have focused on the
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thermodynamic characterization of polymer chains. To our knowledge, the charac-
terization of the thermodynamic properties of aqueous solutions formulated with
soluble oligosaccharide derivatives of chitin or chitosan has not yet been done.
The objective of this study is to evaluate the impact of COS on the thermody-
namic properties of aqueous solutions and to put forward a potential action of these
products on water and other properties of the solutions (viscosity, gelling, etc.). It
will help to evaluate the cryoprotection effect of COS.
7.1 Materials and methods
7.1.1 Thermodynamic characterization of solutions
A differential scanning calorimeter (DSC Diamond; Perkin Elmer) with power
compensation was used in this study. The previously described procedures [117]
have been applied, with the same methods of sample preparation, calibration of the
DSC calorimeter, and precautions for use. COS were added in the IMV + 5% (v/v)
Me2SO solution, with different mass concentrations (mg.mL
1) of hydrated powder
of COS (per unit volume of the IMV + 5% (v/v) Me2SO solution), as listed in
Table 3.
To study the cryoprotective capability of COS as a substitute for Me2SO, the
solutions were studied by DSC using a protocol described elsewhere [117]. This
protocol starts with a cooling from +10°C to 150°C at 100°C.min1, a warming
from 150°C to +10°C at +2.5°C.min1, a cooling from +10°C to 150°C at 2.5°C.
min1, and a warming from 150°C to +20°C at +20°C.min1. The experiments
were repeated three times (n = 3) for each concentration.
7.1.2 Correction of the studied mass concentrations
The studied COS have a residual moisture content. Thus, the mass concentration
of the added powder is not equivalent to the real mass concentration of the added
product. Correction is made according to Eq. (1):
Real mass concentration of COS ¼ Powder mass concentration of hydrated COS
∗ 1 ΨH2O, ini COSð Þ
 
(1)
Real mass concentration of COS (mg.mL1), powder mass concentration
of hydrated COS (mg.mL1), ΨH2O, ini COSð Þ, residual hydration ratio in the
lyophilized powder of purified COS (Ø)
Products Averaged
DP
Averaged
DA (%)
Residual
hydration ratio
after purification
% (w/w)
Powder mass
concentrations
studied
(mg.mL1)
Real mass
concentrations
studied
(mg.mL1)
DSC
sample
mass
(mg)
COS7.5_0 7.5 0 6.5 30; 60; 90; 150 28.05; 56.1;
84.15; 140.3
5
COS10_0 10 0 6.5 0; 25; 50; 100;
150; 200
0; 23.38; 46.75;
93.5; 140.3; 187
10
Table 3.
Table of the studied products, with their characteristics (DP, DA, and residual hydration ratio after
purification) and their studied mass concentrations.
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The actual mass concentrations of COS in the solutions that were studied are
presented in Table 3. In the following analyses, only the actual mass concentration
of COS is considered for a given compound. However, to simplify the notation in
thermograms, the hydrated powdered mass concentration of COS is used to desig-
nate the solutions.
7.1.3 Normalization of the transition enthalpies to 0°C
The amounts of ice formed in solution were estimated using the determination
of the crystallization enthalpy (ΔHc) and the melting enthalpy (ΔHm). To estimate
these amounts, the peak areas were calculated using a sigmoidal curve baseline
(with the Pyris software 11.1.1). During warming the tangents, allowing the calcu-
lation of the sigmoidal line, were positioning, respectively, just before the colloidal
transition and just after the melting peak.
In order to compare the transition enthalpies, a normalization of the measured
values to a specified temperature of 0°C was made. As the enthalpy value of the
transition of water to ice evolves as a function of temperature, the “latent heat of
solidification of supercooled water” (Lf) was obtained at the measured phase
change temperature from Boutron’s [118] data interpolation. His data were calcu-
lated [119] from Angell’s [120] specific heat capacity (Cp) of supercooled water and
from Weast’s Hand Book’s [121] Cp of ice at different temperatures.
The normalization of the measured values to the expected values at the specified
temperature of 0°C considers that the same proportion of solution transits at the
transition temperature (Tt) (ΔHmeas(Tt)/Lf(Tt)) and at 0°C (ΔHnormalized(0°C)/
Lf(0°C)). This equality leads to Eq. (2):
ΔHnormalized 0°Cð Þ ¼
ΔHmeas Ttð Þ ∗Lf 0°Cð Þ
Lf Ttð Þ
(2)
where ∆Hnormalized(0°C) is the transition enthalpy of the sample normalized to
0°C (J.g1), ∆Hmeas(Tt) is the transition enthalpy of the sample measured at a
transition temperature Tt (J.g
1), Lf(Tt) is the transition enthalpy of a pure water
sample measured at a transition temperature Tt (J.g
1), and Lf(0°C) is the transition
enthalpy of a pure water sample measured at 0°C (= 333.4 J.g1) (J.g1).
During cooling, to analyze the crystallization enthalpies, the nucleation temper-
ature (Tn) was considered as the transition temperature (i.e., Tt = Tn). During
warming, to analyze the melting enthalpies, the temperature of the summit of the
melting peak (Tmax) was considered as the transition temperature (i.e., Tt = Tmax).
These are approximations because for a mixture there is not only one transition
temperature.
7.1.4 Comparison of measured and calculated transition enthalpies
with the addition of an inert mass
When a non-hydrated inert mass is added in a solution, a lowering of the
enthalpies of crystallization and melting is expected since this addition decreases, in
proportion, the mass of water present in solution. The term “inert” refers to a
product that does not influence the transition enthalpies (i.e., a product that does
not transit and does not influence the transition of other products). The theoretical
link between the decrease of the transition enthalpies and the decrease of the mass
proportion of water in solution is given by Eq. (3). The comparison of a theoretical
value with a measured one allows estimating the mass of water which transits in
comparison to the mass of water present within the solution. Experimental values
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lower than the theoretical ones materialize an evolution of the proportion of
solution which is crystallized. Indeed, it materializes a deviation in the evolution of
the compound concentrations within the remaining solution (according to
the lever rule).
ΔHcalculated with an inert mass c½ ð Þ ¼ ΔHmeasured c½  ¼ 0ð Þ ∗ΨIMVþ5% v=vð ÞMe2SO (3)
where ∆Hcalculated with an inert mass([c]) is the calculated specific enthalpy for the
transition of liquid water to ice for an IMV + 5% (v/v) Me2SO solution with a
concentration [c] of inert mass (J.g1), ∆Hmeasured([c] = 0) is the experimentally
measured specific enthalpy for the transition of liquid water to ice for a IMV + 5%
(v/v) Me2SO solution = 265.68  3.2 J.g
1 (this specific enthalpy value corresponds
to the average of the three measurements with the IMV + 5% (v/v) Me2SO solution
without COS) (J.g1), and ΨIMVþ5% v=vð Þ Me2SO is the initial mass proportion of the
IMV + 5% (v/v) Me2SO solution in the prepared IMV + 5% (v/v) Me2SO solution
containing an inert mass (Ø).
Eq. (4) allows estimating the initial mass proportion of the IMV + 5% (v/v)
Me2SO solution in the prepared IMV + 5% (v/v) Me2SO solution containing an inert
mass such as COS.
ΨIMVþ5% v=vð ÞMe2SO solð Þ ¼
mIMVþ5%Me2SO
mIMVþ5%Me2SO þmproduct
¼
dIMVþ5%Me2SO ∗ ρH2O ∗Vsol
dIMVþ5%Me2SO ∗ ρH2O ∗Vsol þ product½  ∗Vsol
¼
1014:5
1014:5þ product½ 
(4)
where ΨIMVþ5% v=vð Þ Me2SO is the initial mass proportion of the IMV + 5% (v/v)
Me2SO solution in the prepared IMV + 5% (v/v) Me2SO solution containing an inert
mass (Ø), dIMV + 5%Me2SO is the density of the IMV + 5%(v/v) Me2SO solu-
tion = 1.0145 (experimentally measured with a pipette and a high sensibility
weighing scale) (Ø), ρH2O is the mass volume of water ≈ 1000 (mg.mL
1), Vsol is
the volume of the solution (mL), and [product] is the initial mass concentration of
hydrated product added in solution (mg.mL1).
7.1.5 Estimation of the cryoscopic depression
A cryoscopic depression indicates the action of a dissolved product on the
properties of water molecules in solution, providing information on interactions
that occur between this product and the water molecules. The estimation of the
maximal equilibrium temperature (Tm), for different concentrations of the same
COS introduced in the IMV + 5% (v/v) Me2SO solution, informs about the cryo-
scopic depression induced by the oligosaccharide. Moreover, knowing the temper-
ature (Tm) of a solution allows to estimate, as a function of the temperature, the
supercooling magnitude reached in this mixture (before crystallization).
Due to the kinetic phenomena of heat transfer, it is often imprecise to confuse
the temperature recorded at the maximum of the endothermic melting peak (Tmax)
with the maximum melting point temperature of the ice in solution, because Tm is
less or equal to Tmax [119]. In the kinetic phenomena being influenced by the mass
involved in the melting process, the comparison of the Tmax values becomes diffi-
cult between the series for which the mass of sample studied is different and in
which the mass of water in solution concerned by the melting is different.
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Since the Tmax values cannot be compared and can hardly be associated only
with a cryoscopic phenomenon, we have not realized this comparison. We used an
alternative method for estimating the cryoscopic effect based on the shape of the
thermograms. It consists in the comparison of the size and the peaks spread with
temperature [119].
7.2 Phase transition analysis of crystallizable water
The calculated values of the crystallization and melting enthalpies of the solu-
tions were normalized to 0°C and represented in Figure 1. The calculation of the
phase change enthalpy expected following the addition of an inert mass was
performed in the range of the concentrations studied, using Eqs. (3) and (4). These
values were plotted (Figure 1), with measured enthalpy values (normalized to
0°C), as a function of the initial COS concentration.
A sharp decrease in the ΔHc and ΔHm values is observed as a function of the
mass concentration of COS introduced, and this decrease seems affine. For the same
mass concentration of non-hydrated powder studied, the differences between ΔHc
and ΔHm are small. Until 50 mg.mL
1, a good correlation is observable between the
calculated mass enthalpies following the addition of a non-hydrated inert mass and
the measured mass enthalpies in the presence of COS (cf. Figure 1). COS molecules
added in the solution can replace part of the water molecules present in the solution
and thus reduce the amount of crystallizable water in mass proportion (as materi-
alized by the orange line in Figure 1). To play an additional role, the CPA molecules
must either bind to a portion of the water molecules to prevent their crystallization
or promote the glass-forming tendency of free water during cooling. Based on
Figure 1, COS do not seem to have significant effects, although these effects
increase for the higher COS concentration (> 100 mg.mL1).
For the smallest COS concentrations, if the COS could bind to a part of the
water, or highly favor the vitrification, then a difference between calculated
enthalpies and experimental enthalpies or a difference between the crystallization
enthalpies and the melting enthalpies (for a nominative mass of COS introduced in
solution) would have been expected. These results imply that the addition of COS in
Figure 1.
Crystallization and melting enthalpies, normalized to 0°C, for the different solutions containing COS. Here the
calculated transition enthalpies are also materialized in the case of the addition of a non-hydrated inert mass in
solution. The standard deviations are calculated according to the three data obtained for each value. The
standard deviation of the calculated enthalpy is the standard deviation of the measured value without COS.
14
Cryopreservation - Current Advances and Evaluations
the solution does not disturb further the ability of water molecules to crystallize.
Thus, the COS presence does not alter either the amount of bounded water or the
quantity of bulk water that vitrified.
For the highest COS concentrations, the amount of water that can crystallize is
reduced, as indicated by the smaller normalized values of ΔHc and ΔHm. This
decrease in crystallization and melting enthalpies implies a decrease in the amount
of ice formed. Because normalized values are lower than the calculated, we argue
that it is the materialization of the capability of COS to stabilize the remaining
solution and to limit the crystallization of a part of the water molecules in the
remaining solution.
COS, therefore, serve the purpose of reducing ice formation during cryopreser-
vation procedures. However, their mode of action and its consequences for cells
deserve to be studied deeper.
7.3 Cryoscopic depression induced by the addition of COS
As could be seen in Figure 2, when COS is added, the maximum of the heat flow
related to the melting endothermic peaks appears to be smaller, and the peaks are
shifted toward the low temperatures.
When there is little ice in the sample, the effects responsible for the temperature
difference between Tm and Tmax decrease. Thus, the decrease in the amount of ice
formed when the amount of COS increases (cf. Figure 1) could explain the lowering
of Tmax (cf. Figure 2) without cryoscopic effect. When there is a smaller amount of
ice and fewer phenomena that may imply the shift of the temperature of the
Figure 2.
Zoom on the bottom of the melting peaks obtained for the mixture: IMV + 5% (v/v) Me2SO + [COS10_0].
Observation of the COS influence on the shape of the melting peaks. Protocol, 2. Sample volume = 10 μL.
Warming rate = +2.5°C.min1. Data range, normal. All cooling and warming thermograms were straightened
up from100 to80°C and then lined up at 0.0 mW. The mass concentrations of the studied hydrated powder
are equal to 0, 12.5, 25, 100, and 200 mg.mL1. Two endothermic peaks are observable on each of these
thermograms, a large one which is associated to the melting of the ice previously crystallized within the sample
and a small one which is an anomaly. This anomaly of melting is systematically present during the analysis of
slow-freezing solutions, linked to the melting of the previously condensed and crystallized ambient humidity of
the air encapsulated within the sample pan. This humidity could be from the previous ambient air in the
laboratory or from the equilibration at the vapor pressure of water between the encapsulated air and the sample
aqueous solution or from a combination of both.
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melting peak summit, the melting peak is smaller, and then, the temperature of the
peak’s summit is shifted toward low temperatures.
However, the offset that is observed at the onset of the peaks cannot be associ-
ated with a reduction in the amount of ice that melts during warming. This shift
indicates that there is a change in the amount of ice transiting at lower tempera-
tures. The amount of water that melts as a function of temperature is greater at
lower temperatures for the solutions with COS (cf. Figure 2), even if, in the
presence of COS, the total amount of ice previously formed is lower. This phenom-
enon is the materialization of a slight cryoscopic effect linked to the addition of COS
in solution. This effect is, however, difficult to quantify and remains below 0.5°C
(cf. Figure 2).
The presence of a weak cryoscopic depression associated with the addition of
COS in the IMV + 5% (v/v) Me2SO solution involves the addition of COS having
little or no influence on the osmolality of the studied solutions. Further verifications
will nevertheless have to be made to verify these results, especially by studying the
characteristics of the mixture: “H2O-COS.” Based on these preliminary findings, we
will consider that COS compounds can be added to cryopreservation solutions
without fear of a significant increase or acceleration of cell dehydration.
8. Conclusion on the COS usage for cryopreservation
According to this first thermodynamic characterization, the use of COS as CPA
is debatable, as are their cryoprotective capabilities.
COS appear to be biocompatible in solution, and no disruption to mouse embryo
development has occurred when COS were evaluated. COS have a significant influ-
ence on lowering the amount of crystallizable ice in solution, without participating
in cell dehydration. Indeed, their addition in solution replaces a significant part of
water, without significant osmotic effect. This is an interesting use in slow-freezing
cryopreservation since it makes it possible to reduce the mechanical damage asso-
ciated with the formation of ice, without change in the equilibrium of the osmotic
balance with the intracellular media. We can thus assume that the use of such a
product does not promote the mechanisms of dehydration of the intracellular
medium.
However, COS do not seem able to influence the proportion of IMV + 5% (v/v)
Me2SO solution remaining liquid during freezing. As a result, they cannot partici-
pate in the main protections associated with CPA. Using these compounds without
any other CPA has, therefore, to be discarded. COS do not participate in the
equilibration of osmotic pressures between intra- and extracellular media. Thus,
they dehydrate the overconcentrated residual solution, without modifying the mass
proportion of crystallized water and without dehydrating the cells. They act only in
the extracellular medium by inducing a steric hindrance and by increasing the
solution viscosity. They seem to contribute to the stabilization of the extracellular
noncrystalline medium.
Combined with penetrating cryoprotectants, we assume that COS can promote a
decrease in the use of penetrating CPA while ensuring the successful vitrification of
intercrystalline spans. Nevertheless, several questions remain about the action of
COS in solution. It is particularly possible to question their interactions with water
molecules. Similarly, it is difficult to know how these compounds interact with
Me2SO. In order to further characterize the role of these compounds in water
solution, it will be necessary to characterize them in simpler binary solutions com-
posed of COS and water. It would also be necessary to study the influence of COS on
the ice crystal organization in cryopreserved samples (notably to study the
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influence of COS on the average size of intercrystalline spans). Further experi-
ments, particularly on their ability to increase the glass-forming tendency of the
remaining solution, should be conducted in the future.
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